As of April 9, 2026, the CDC reports 1,714 laboratory-confirmed measles cases in the United States for the year, spanning 33 jurisdictions including major outbreaks in Utah, South Carolina, Texas, and Florida, with 94% outbreak-associated and most among unvaccinated individuals. This drives Polymarket trader consensus toward 1,800 total cases by April 30 (61% implied probability on that bin), reflecting sustained transmission in communities below the 95% vaccination threshold for herd immunity amid a highly contagious virus (R0 12–18). Recent weekly growth slowed to about 2.6%, but momentum persists from 17 new 2026 outbreaks. Key uncertainties include public health responses and imported cases; watch for CDC's next surveillance update this week.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · GüncellendiABD'de 30 Nisan'a kadar kızamık vakaları?
ABD'de 30 Nisan'a kadar kızamık vakaları?
$189,917 Hac.
$189,917 Hac.
30 Nis 2026
1800
58%
1850
19%
1900
6%
1950
3%
2000
2%
2100
2%
2200
2%
$189,917 Hac.
$189,917 Hac.
30 Nis 2026
1800
$48,139 Hac.
58%
1850
$4,832 Hac.
19%
1900
$50,744 Hac.
6%
1950
$20,403 Hac.
3%
2000
$42,586 Hac.
2%
2100
$7,273 Hac.
2%
2200
$15,939 Hac.
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 laboratory-confirmed measles cases in the United States for the year, spanning 33 jurisdictions including major outbreaks in Utah, South Carolina, Texas, and Florida, with 94% outbreak-associated and most among unvaccinated individuals. This drives Polymarket trader consensus toward 1,800 total cases by April 30 (61% implied probability on that bin), reflecting sustained transmission in communities below the 95% vaccination threshold for herd immunity amid a highly contagious virus (R0 12–18). Recent weekly growth slowed to about 2.6%, but momentum persists from 17 new 2026 outbreaks. Key uncertainties include public health responses and imported cases; watch for CDC's next surveillance update this week.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Piyasa Açıldı: Mar 27, 2026, 1:49 PM ET
Hacim
$189,917Bitiş Tarihi
30 Nis 2026Piyasa Açıldı
Mar 27, 2026, 1:49 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of April 9, 2026, the CDC reports 1,714 laboratory-confirmed measles cases in the United States for the year, spanning 33 jurisdictions including major outbreaks in Utah, South Carolina, Texas, and Florida, with 94% outbreak-associated and most among unvaccinated individuals. This drives Polymarket trader consensus toward 1,800 total cases by April 30 (61% implied probability on that bin), reflecting sustained transmission in communities below the 95% vaccination threshold for herd immunity amid a highly contagious virus (R0 12–18). Recent weekly growth slowed to about 2.6%, but momentum persists from 17 new 2026 outbreaks. Key uncertainties include public health responses and imported cases; watch for CDC's next surveillance update this week.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Hacim
$189,917Bitiş Tarihi
30 Nis 2026Piyasa Açıldı
Mar 27, 2026, 1:49 PM ETResolver
0x65070BE91...As of April 9, 2026, the CDC reports 1,714 laboratory-confirmed measles cases in the United States for the year, spanning 33 jurisdictions including major outbreaks in Utah, South Carolina, Texas, and Florida, with 94% outbreak-associated and most among unvaccinated individuals. This drives Polymarket trader consensus toward 1,800 total cases by April 30 (61% implied probability on that bin), reflecting sustained transmission in communities below the 95% vaccination threshold for herd immunity amid a highly contagious virus (R0 12–18). Recent weekly growth slowed to about 2.6%, but momentum persists from 17 new 2026 outbreaks. Key uncertainties include public health responses and imported cases; watch for CDC's next surveillance update this week.
Polymarket verilerine atıfta bulunan deneysel AI tarafından oluşturulmuş özet. Bu bir işlem tavsiyesi değildir ve bu piyasanın nasıl çözümlendiğinde hiçbir rolü yoktur. · Güncellendi
Harici bağlantılara dikkat edin.
Harici bağlantılara dikkat edin.
Sıkça Sorulan Sorular